Progressive Reports September 2024 Results

MAYFIELD VILLAGE, OHIO, Oct. 15, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended September 30, 2024 and the third quarter of 2024:   September Quarter (millions, except per share amounts and ratios; unaudited)  2024  2024    2023    Change Net premiums written $     6,570.0 $ 19,455.6   $ 15,593.8     25 % Net premiums earned $     6,262.7 $ 18,296.7  ...

Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD – The Liver Meeting® 2024

WARMINSTER, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with...

NEWTON GOLF Company Expands its Global Presence with the Launch of Newton Motion Shafts in Japan

Newton Motion shafts now available in 50 of Japan’s largest golf retailers and through GDO, the country’s leading e-commerce platform CAMARILLO, CA, Oct. 15, 2024 (GLOBE NEWSWIRE) — NEWTON GOLF Company (Nasdaq: SPGC) (“NEWTON...

STRATA Skin Sciences’ XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference

HORSHAM, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of...

Douglas Dynamics Announces Third Quarter 2024 Earnings Release and Conference Call

MILWAUKEE, Oct. 15, 2024 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced that it will release financial results for the third...

MaxCyte Appoints Cynthia Collins to its Board of Directors

ROCKVILLE, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics...

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

SANTA ANA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural...

Prime Matter Labs Names Four Industry Leaders to New Advisory Board

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — Prime Matter Labs (PML), a leading beauty and personal care product development and manufacturing platform, today announced the formation of its first Advisory Board tasked with...

Microchip Releases 20 Advanced Wi-Fi® Products for Industrial and Commercial Applications

CHANDLER, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) — With Industry 4.0, the rapid rise of Artificial Intelligence (AI), digitized manufacturing and the age of IoT everything, the demand for wireless connectivity in commercial and...

Xometry to Announce Third Quarter 2024 Financial Results On November 5, 2024

NORTH BETHESDA, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global AI-powered marketplace connecting enterprise buyers with suppliers of manufacturing services, today announced it will report its third quarter 2024...

Franklin Electric Schedules Its Third Quarter 2024 Earnings Release and Conference Call

FORT WAYNE, Ind., Oct. 15, 2024 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) will release its third quarter 2024 earnings at 8:00 am ET on Tuesday, October 29, 2024. A conference call...

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week

WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today...

Second Gold for Regula at the Merit Awards for Cybersecurity

RESTON, Va., Oct. 15, 2024 (GLOBE NEWSWIRE) — This independent award recognizes Regula’s innovation and technical expertise in identity verification. Even after more than 30 years in the market, Regula continues to explore the...

CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB)

• On track to report topline data from the Phase 2b trial in December 2024 • Neflamapimod has the potential to restore function and improve cognitive and motor functions in DLB patients • 96% of patients...

Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting

Carlsbad, CA, Oct. 15, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and...

Vestaron Corporation Announces Strategic Collaboration with ADM for Production of Peptide-Based Crop Protection Products

Durham, North Carolina, Oct. 15, 2024 (GLOBE NEWSWIRE) — Vestaron Corporation, a leading innovator in sustainable crop protection solutions, is pleased to announce a long-term strategic agreement with ADM for the production of Vestaron...

Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant...

Landstar to Release Third Quarter Results on Tuesday, October 29, 2024

JACKSONVILLE, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR), announced today it will release its 2024 third quarter results after the market closes on Tuesday, October 29, 2024, and will then...

ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors

WESTON, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces that Stephen...

Watsco Schedules Third Quarter Earnings Conference Call on Wednesday, October 23, 2024

MIAMI, Oct. 15, 2024 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that it will host a conference call to discuss its 2024 third quarter financial results on Wednesday, October 23, 2024 at...

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) — BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the...

Insurance Fraud Spurs Growth in Dashboard Camera Market – Future Market Insights, Inc.

NEWARK, Del, Oct. 15, 2024 (GLOBE NEWSWIRE) — The global dashboard camera market is projected to reach USD 18,369.5 million by 2034, with an estimated value of USD 3,364.5 million in 2024. This industry...

Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD

SOL-1 is now expected to be enrolled and fully randomized by year-end 2024 Topline clinical data from SOL-1 are now expected in Q4 2025 BEDFORD, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix,...

Attovia Therapeutics Appoints Chief Financial Officer

FREMONT, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — Attovia Therapeutics announced the appointment of Steven Chan as Chief Financial Officer. Mr. Chan brings extensive financial strategy and operational experience and joins Attovia after serving...

ZenaTech Announces First US Trial of the ZenaDrone IQ Nano Drone for Inventory Management by an Auto Parts Manufacturer

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise SaaS (Software-as-a-Service) solutions, today announced that its subsidiary, ZenaDrone, has...

Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference

WAYNE, PA., Oct. 15, 2024 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which...

MRC Global Announces Actions to Strengthen Its Capital Structure

Agrees to Repurchase Preferred Stock Launches Term Loan B Financing to Fund Repurchase Pursues Amendment to ABL Facility to Extend Maturity Provides Preliminary Third Quarter 2024 Financial Results HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE)...

CECO Environmental Upsizes Credit Facility to $400 Million

DALLAS, Oct. 15, 2024 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment, and industrial equipment, has announced a significant upsize in...

Allyx Therapeutics Awarded $3.3 Million NIH Grant to Support Further Clinical Studies of Lead Candidate ALX-001

NEW HAVEN, Conn., Oct. 15, 2024 (GLOBE NEWSWIRE) — Allyx Therapeutics announced today that it has been awarded a $3.3 million grant from the National Institutes of Health as part of its Small Business...

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS

LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first patient...

Amwell to report third quarter 2024 operating results

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the earnings alert via...

Illinois Schools Gain Free Access to STEM Career Exploration Tools

SPRINGFIELD, Ill., Oct. 15, 2024 (GLOBE NEWSWIRE) — Learning Blade, a STEM career exploration platform for grades 5–9, is now available to Illinois educators at no cost. Through mission-based adventures, Learning Blade empowers students...

Wisconsin Schools Gain Free Access to STEM Career Exploration Tools

MADISON, Wis., Oct. 15, 2024 (GLOBE NEWSWIRE) — Learning Blade, a STEM career exploration platform for grades 5–9, is now available to Wisconsin educators at no cost. Through mission-based adventures, Learning Blade empowers students...

Massachusetts Schools Gain Free Access to STEM Career Exploration Tools

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Learning Blade, a STEM career exploration platform for grades 5–9, is now available to Massachusetts educators at no cost. Through mission-based adventures, Learning Blade empowers students to...

Atavistik Bio Announces Nomination of Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor

AKT1 E17K mutation is a clinically validated oncogene that impacts greater than 40,000 cancer patients per year in the United States, with the highest prevalence in breast, endometrial, and prostate cancers As a selective...

Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

BETHESDA, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule...

Coteau Grove Project Celebrates Two-Year Anniversary of Playing Shows for a Good Cause

LAFAYETTE, La., Oct. 15, 2024 (GLOBE NEWSWIRE) — Coteau Grove Project (“Coteau Grove band”) is pleased to celebrate its two-year anniversary. Coteau Grove Project was formed in 2022 with a unique charitable mission of...

Gray Media to Debut New National Anthem Rendition Across All Stations

Atlanta, Georgia, Oct. 15, 2024 (GLOBE NEWSWIRE) — Gray Media (NYSE: GTN) is proud to announce the release of a new National Anthem rendition, which will begin airing across all Gray television stations starting...

Fossil Group, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

RICHARDSON, Texas, Oct. 15, 2024 (GLOBE NEWSWIRE) —  Fossil Group, Inc. (NASDAQ: FOSL) (the “Company”) today announced that it is granting an equity award as a material inducement to the employment of the Company’s newly-hired...

Advent Technologies Reports Q2 2024 Results

Operational Highlights Work continued on the Airbus-sponsored project to benchmark HT-PEM fuel cell MEAs in aviation for the second quarter. The project continued as planned without delays. Met milestones with the U.S. Department of...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial...

Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting

GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced the presentation of data from its...

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

— Topline Results Expected Q2 2025 — WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory therapies for the...

Flagship Communities Real Estate Investment Trust to Host Conference Call for Third Quarter 2024 Results

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced...

Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance

Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5% Record Equipment and Service Backlog of $11.7 Million First Half Revenue Growth of 10% YOY, First Half Net Income Growth of 13% YOY Expects Continued...

DT Midstream to Announce Third Quarter 2024 Financial Results, Schedules Earnings Call

DETROIT, Oct. 15, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) plans to announce third quarter 2024 financial results before the market opens on Tuesday, October 29, 2024. DT Midstream has scheduled a...

In-Line Transit Time Ultrasonic Flow Meter Market is Projected to Reach US$ 949.1 Million by 2034 | Fact.MR Report

Rockville, MD , Oct. 15, 2024 (GLOBE NEWSWIRE) — The global In-Line Transit Time Ultrasonic Flow Meter Market is estimated to be US$ 515.2 million in 2024 and is projected to grow steadily with...

Glycolic Acid Market to Surpass USD 782.9 Million by 2034, Driven by Growing Demand in Skincare and Industrial Applications | Future Market Insights, Inc.

NEWARK, Del, Oct. 15, 2024 (GLOBE NEWSWIRE) — The Glycolic Acid Market is poised for steady growth in the coming decade, primarily driven by rising demand from the cosmetic and skincare sectors. Glycolic acid,...

Planet 13 Strengthens Florida Retail Footprint with Opening of 28th Dispensary Located in Port Orange near Daytona Beach

Las Vegas, Oct. 15, 2024 (GLOBE NEWSWIRE) —  Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the upcoming grand opening of...

AI knowledge thought leaders and practitioners to convene at eGain Solve 2024

SUNNYVALE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the AI knowledge platform for customer service, today announced the eGain Solve 2024 conference to usher in the era of AI knowledge to...

Safety Valves Market to hit $6.5 Bn by 2032, Says Global Market Insights Inc.

Selbyville, Delaware,, Oct. 15, 2024 (GLOBE NEWSWIRE) — The safety valves market is predicted to cross USD 6.5 billion by 2032, as reported in a research study by Global Market Insights Inc. As economies...